Personalized medicine, including biomarker-driven diagnostics, CAR-T cell therapies, and gene-level treatments, is creating new opportunities for life sciences innovation. But securing meaningful patent protection in this space is anything but one-size-fits-all. Traditional patent frameworks often fall short when applied to therapies tailored to individual genetic profiles, and evolving eligibility standards at the USPTO and internationally add another layer of complexity.

Join Sterne Kessler’s Paul Calvo, Ph.D. and Emily Tkac as they examine the challenges and practical strategies when protecting innovation in this rapidly evolving space.

Topics to be covered during the webinar include:

  • Subject matter eligibility under Mayo/Alice and the lessons of Vanda Pharmaceuticals
  • The USPTO’s guidance on AI-assisted diagnostics
  • Divided infringement risks and how to avoid them
  • Claim drafting strategies across the U.S., Europe, China, and Japan

Gain practical strategies to strengthen patent positions, anticipate enforcement challenges, and build global protection for personalized medicine innovations.

Continuing Legal Education Credits

General CLE credit is pending for VA, CA, TX, NY, and IL.

Related Professionals

Related Industries

Related Services